Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitors

Fig. 1

Metabolic profiles of MCF-7, MDA-MB-231 and Hs578T cells. Mitochondrial oxidative phosphorylation and glycolysis were assessed using XFe24 Seahorse to measure basal OCR (untreated condition) and maximal OCR (after oligomycin and FCCP treatment) and basal ECAR (untreated condition) and maximal ECAR (after oligomycin treatment). The results are depicted as the mean ± S.D. of at least three independent measurements

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us